NCT05111470 (Overhead) is a NA clinical trial of Arm throws with his dominant arm in Kayak Polo, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT05111470?

NCT05111470 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT05111470?

Interventions in NCT05111470: Arm throws with his dominant arm.

What condition does NCT05111470 study?

NCT05111470 studies Kayak Polo, Overhead.

Is NCT05111470 still recruiting?

NCT05111470 is currently completed. Last updated 8 November 2021.

Last reviewed 2021-11-08 · How we verify

NCT05111470: Overhead

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of the Kinematics of the Shoulder Complex in Sports "Overhead" Gestures Such as Kayaking Polo Throwing (Overhead)

Completed NA Last updated 8 November 2021

What this trial tests

NA trial testing Arm throws with his dominant arm in Kayak Polo in 20 participants. Completed in 21 January 2021.

Timeline

29 October 2019

Primary endpoint
29 October 2020

21 January 2021

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	29 October 2019
Primary completion	29 October 2020
Estimated completion	21 January 2021
Sites	1 location across France

Drugs / interventions tested

Arm throws with his dominant arm

Conditions studied

Kayak Polo — all drugs for Kayak Polo →
Overhead — all drugs for Overhead →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

18 and older, male only, with Kayak Polo or Overhead. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to analyze the throwing gesture specific to the kayak polo. A throw in a seated position with fixation of the pelvis (by the seat) and antepulsion of the hip ipsilateral to the throwing shoulder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05111470 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 8 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing